Controversially, in vivo xenograft analyses of breast cancer cell lines were unable to demonstrate ALDH+ or CD44+/CD24- CSC localization patterns, or demonstrate a correlation between the frequency of CD44+/CD24- CSCs and tumor metastasis as observed in patients with breast cancer [47, 48]. This evidence concerns the gene CD44 and breast carcinoma.